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Abstract B-lymphocytes are known to synthesise the P2X7 subtype of the P2X
purinergic receptor family, however the identification of the other six P2X subtypes on
these cells has been limited by the absence of specific antibodies. In this study, we used
a panel of anti-P2X polyclonal antibodies and confocal microscopy to examine the
presence of each P2X receptor on human B-lymphocytes. We observed that P2X1,
P2X2, P2X4 and P2X7 subtypes, but not P2X3, P2X5 and P2X6 subtypes, are present on
B-lymphocytes.
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Introduction

P2X-type purinergic receptors are ligand-gated cation channels which are activated by
extracellular adenosine 5’-triphosphate (ATP). To date seven subtypes of P2X
receptors, P2X1 to P2X7, have been cloned (Buell et al. 1996a). These receptors are well
recognised to have a role in nervous and muscle tissues where they function in cell-cell
communication (Ralevic and Burnstock 1998), and although they have been identified
on cells of haematopoietic origin their function in these cells is less clearly defined.
P2X7 receptor immunoreactivity on human lymphocytes and monocytes has been
demonstrated by binding of a monoclonal antibody against this receptor (Gu et al.
2000). The P2X7 receptor has an established role in the apoptosis of haematopoietic
cells such as macrophages and dendritic cells (Lammas et al. 1997; Coutinho-Silva et al.
1999). Both the distribution and function of P2X1 receptors on haematopoietic cells are
less well defined, although there is some evidence that this receptor is required for
human blood platelets to function normally (Oury et al. 2000). Moreover the presence
of other P2X receptors on lymphocytes is not known. In this study, confocal microscopy
was used to identify which P2X subtypes are present on human B-lymphocytes from
patients with chronic lymphocytic leukemia (CLL) using a panel of polyclonal
antibodies raised against extracellular epitopes of the P2X1 to P2X7 receptors.
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Materials and methods

Antibodies

Rabbit polyclonal antibodies produced against non-homologous extracellular epitopes
of P2X receptors have been previously described (Dutton et al. 1999; Worthington et al.
1999b; Yunaev et al. 2000). Each epitope was selected in part to ensure no crossreactivity with any other P2X subtype (Dutton et al. 1999). Each P2X polyclonal
antibody binds selectively and specifically as shown by Western blots in a range of
tissue although not all subtypes are present in all tissues (Worthington et al. 1999a;
Worthington et al. 1999b; Li et al. 2000). In addition, specificity was confirmed using
specific P2X cRNA transfected into Xenopus oocytes (Dutton et al. 1999). Specific
P2X polyclonal antibody was added to transfected cells in the presence or absence of
specific P2X epitope or non-specific epitope to demonstrate only the specific antibody
reacted with the specific epitope (Dutton et al. 1999). Moreover, specificity was also
evident in that only sub-populations of cells were labelled.
Murine anti-human P2X7 receptor monoclonal antibody (clone L4) (Buell et al.
1998) was purified from hybridoma supernatant using a Protein A-Sepharose Fast Flow
Column (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer’s
instructions. Murine anti-human CD19 (clone HD37) and isotype control antibodies
were purchased from Dako A/S (Glostrup, Denmark). Cy2- or Cy5-conjugated donkey
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anti-rabbit antibodies and Cy2-conjugated donkey anti-murine antibody were obtained
from Jackson ImmunoResearch (West Grove, PE).

Preparation of mononuclear cells

Heparinised venous blood from 8 B-CLL subjects was diluted with an equal volume of
RPMI-1640 (Sigma, St Louis, MO) and the mononuclear cells separated by densitygradient centrifugation over Ficoll-Paque (Pharmacia Biotech). The mononuclear cells
were washed twice with RPMI-1640. The mononuclear cells were resuspended at 1 x
106 cells/mL in RPMI-1640 containing 10% heat inactivated foetal calf serum (Life
Technologies, Grand Island, NY) and 25 µg/mL gentamycin (Delta West, Perth,
Australia). Cells (5 x 105 cells/well) were incubated for 60 min in wells of 48-well
plates (Falcon, Becton Dickinson, Franklin Lakes, NJ) containing poly-L-lysine-coated
(0.1 mg/ml; Sigma) glass coverslips. Adherent cells were fixed with cold 4%
paraformaldehyde in 0.01 M phosphate-buffered saline (PBS) (pH 7.2) for 4 min and
washed twice with PBS.

Immunofluorescence staining and confocal microscopy

Fixed cells on poly-L-lysine-coated glass coverslips in 48-well plates were incubated
with 20% normal horse serum in PBS for 60 min, then incubated with primary antibody
for 60 min, washed once with PBS and finally labelled with secondary antibody for 60
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min. Cells were then washed twice with PBS before mounting the coverslips on slides
in 50% glycerol in PBS. The identity of B-CLL cells was confirmed by double labelling
with anti-CD19 antibody. Cells were visualised with a Leica TCS NT UV laser confocal
microscope system with the pinhole set at 1.0. Preimmune sera and murine isotype
control antibodies were used routinely as negative controls and showed no staining.
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Results

Human B-lymphocytes, identified by anti-CD19 monoclonal antibody binding (Fig.
1A), were stained with an anti-P2X7 receptor polyclonal antibody (Fig. 1B). Two-colour
confocal microscopy demonstrated that B- lymphocytes stained positively for the P2X7
receptor with staining intensity varying from weak to strong. There was clear evidence
of puncta formation of P2X7 receptors on the cell surface (Fig. 1C,D). Heavily stained
cells were characterised by overlapping puncta (results not shown). A similar
distribution of P2X7 receptors on the cell surface was observed with the anti-P2X7
receptor monoclonal antibody (Fig. 1E).
The anti-P2X1 receptor polyclonal antibody labelled approximately half the Blymphocyte population with weak to moderate staining intensity (Fig 2A,B,C), except
in one subject (CLL 1) in whom the staining was weak and confined to only a small
number of cells (results not shown). P2X1 receptor immunoreactivity was characterised
by puncta formation on the cell surface similar to that observed for the P2X7 receptor
(Fig. 2C,D). However at lower levels of P2X1 receptor staining the distribution was
more diffuse, while at high levels the puncta began to merge (results not shown). Blymphocytes from all subjects examined had moderate levels of P2X2 receptors but this
was restricted to less than half the population of cells. Puncta of P2X2 receptors were
also observed on the surface of B-lymphocytes (Fig. 2E). P2X4 receptor staining was
the most variable of the different P2X subtypes. Cells positive for the P2X4 receptor had
weak to moderate levels of staining in a large proportion on B-lymphocytes from three
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subjects (CLL 1, 5 and 6) (Fig. 2F) but weaker levels and only in a small minority of
cells from others (CLL 2, 3 and 4) (results not shown). The P2X3, P2X5 and P2X6
receptors were absent from human B-lymphocytes, although occasional examples of
cells with negligible to moderate staining showing either a diffuse distribution or puncta
formation were observed (results not shown). Thus P2X1, P2X2, P2X4 and P2X7
receptors were present on human B-lymphocytes (Table 1).
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Discussion

In this study, we used a panel of polyclonal antibodies raised against extracellular
epitopes of the seven P2X subtypes to examine the presence of these receptors on Blymphocytes. Subjects with CLL were studied because B-lymphocytes are the major
mononuclear cell type present and are clonal in origin. The polyclonal antibodies
against the P2X1 to P2X7 subtypes have been previously shown to bind to their
respective P2X receptors in human embryonic kidney cells, human salivary gland
epithelial cells and sympathetic ganglia (Worthington et al. 1999a; Barden and Bennett
2000; Li et al. 2000). In epithelial cells and ganglia there is evidence of P2X receptor
puncta distributed over the cell surface, similar to that observed here in this study (Fig.
1D). The physiological significance of this punctate distribution is uncertain but it is
striking that lymphoid, epithelial and nervous tissue are similar. We have previously
shown P2X7 receptor immunoreactivity on human B-lymphocytes using flow cytometry
(Gu et al. 2000), and our results using confocal microscopy demonstrate the punctate
distribution of these receptors on B-lymphocytes.
In this study we show for the first time that B-lymphocytes display P2X1, P2X2
and P2X4 receptor immunoreactivity. The P2X1 receptor was detected in a proportion of
B-lymphocytes from all subjects examined (Fig. 2B,C,D). The presence of the P2X1
receptor on leucocytes is controversial. P2X1 receptor mRNA has been identified in
peripheral blood leucocytes (Longhurst et al. 1996), and in cultured macrophages and
dendritic cells (Berchtold et al. 1999). Moreover polyclonal antibodies have been used
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to identify the P2X1 receptor in the HL-60 myeloid leukaemic cell line (Buell et al.
1996b) and rodent thymocytes (Chvatchko et al. 1996; Glass et al. 2000). However
these positive observations are in contrast with previous results in which the P2X1
receptor was detected in mononuclear cell preparations from normal subjects by
immunoblotting but its presence on leucocytes was attributed to contaminating platelets
(Clifford et al. 1998).
Both the P2X2 and P2X4 receptors were observed on B-lymphocytes (Fig. 2E,F).
P2X2 receptor mRNA has been observed in murine thymocytes (Freedman et al. 1999)
but was not detected in human mononuclear cells (Adrian et al. 2000). However, at the
protein level, others using a polyclonal antibody have detected the P2X4 receptor in rat
thymocytes but found specific mRNA to be absent suggesting that P2X4 receptor
mRNA may be short-lived (Glass et al. 2000).
Previous studies (Bretschneider et al. 1995, Markwardt et al. 1997) using the
voltage-clamp technique provided evidence that human B-lymphocytes have only nondesensitising ATP-activated cation channels, a feature characteristic of the P2X7
receptor but not P2X1 or P2X4 receptors. The contrasting results between these
functional studies and those observed in this immunocytochemical study may relate to
differences in the B-lymphocytes used. Markwardt and coworkers used tonsillar and
Epstein-Barr virus-transformed tonsillar B lymphocytes, while malignant Blymphocytes were used here. Alternatively, the state of lymphocyte differentiation
maybe a controlling determinant of P2X synthesis.
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The P2X3, P2X5 and P2X6 receptors were absent from B-lymphocytes, although
we did find traces of these receptors in cells from some subjects. The absence of the
P2X3 receptor is consistent with the inability to find mRNA for this receptor in
mononuclear cells from normal subjects (Adrian et al. 2000), however this same group
reported that mononuclear cells contain high levels of P2X5 receptor mRNA. Given the
absence of the P2X5 subtype in B-lymphocytes observed here, the results suggests that
T cells, which are the predominant population in mononuclear cell preparations from
normal subjects, may have accounted for the P2X5 receptor transcript detected by
Adrian et al. (2000). The detection of the P2X6 receptor on human lymphocytes was
negative in agreement with studies using an anti-P2X6 polyclonal antibody which failed
to detect this receptor in rat thymocytes (Glass et al. 2000).

Acknowledgements We thank Ben Gu for purification of the L4 monoclonal antibody.
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Table 1 Immunoreactivities for P2X receptor subtypes on B-lymphocytes
CLL

P2X1

P2X2

P2X3

P2X4

P2X5

P2X6

P2X7

1

±

+

-

+

-

-

+

2

+

+

-

±

-

-

+

3

+

+

-

±

-

-

+

4

+

+

-

±

-

-

+

5

+

+

-

+

-

-

+

6

+

nd

nd

+

nd

nd

+

7

nd

nd

nd

nd

nd

nd

+

8

nd

nd

nd

nd

nd

nd

+

-, absent; ±, present but on a small minority of cells; +, present; nd, not determined
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Figure Legends

Fig. 1 Immunoreactivity for P2X7 receptors on B-lymphocytes. Confocal images (from
the same low power field of view) using two-colour immunofluorescence staining show
anti-CD19 monoclonal antibody (A) and anti-P2X7 receptor polyclonal antibody (B)
labelling of B-lymphocytes. Note the presence of a cell (arrow) which labels for the
P2X7 receptor but not for CD19. Confocal images of B-lymphocytes labelled with the
anti-P2X7 receptor polyclonal (C,D) or monoclonal (E) antibody demonstrate the
distribution of P2X7 receptors. Sections of lymphocytes (C,E) show similar surface
staining with either antibody. A superior view of a lymphocyte (D) demonstrates P2X7
receptor puncta on the cell surface. Preimmune sera and murine isotype control
antibody were included as negative controls and showed no staining (F). Scale bars 5
µm (A,B,F) and 1 µm (C,D,E).

Fig. 2 Immunoreactivities for P2X1, P2X2 and P2X4 receptors on B-lymphocytes.
Confocal images (from the same low power field of view) using two-colour
immunofluorescence staining show anti-CD19 monoclonal antibody (A) and anti-P2X1
receptor polyclonal antibody (B) labelling of B-lymphocytes. Note the presence of cells
(arrows) which label for CD19 but not for the P2X1 receptor. Section (C) or superior
views (D,E,F) of B-lymphocytes labelled with the anti-P2X1 (C,D), -P2X2 (E) or -P2X4
(F) receptor polyclonal antibody. Scale bars 5 µm (A,B), 2 µm (C) and 1 µm (D,E,F).

